IDMP Ontology Community of Interest Meeting


JavaScript Disabled
JavaScript Disabled
(Date and time are shown in your browser's local time zone)

Event Type

Join us for our upcoming Community of Interest meeting to learn more about our IDMP-O initiative. Our newly launched IDMP-O version 1.0 covers all five ISO IDMP standards, enabling a broad range of use cases around substance identification, regulatory processes integration with manufacturing, supply-chain analytics, therapeutic indications, representation of jurisdiction-agnostic medicinal products and pharmacovigilance.

Our focus for 2024 is on supporting the production implementation of IDMP-O in the pharmaceutical sector. We’re introducing dedicated support and training programs to assist pharma and industry professionals in integrating IDMP-O into their workflows and systems. Parallel to our Phase 3 project activities, governance will be further secured by ISO Technical Specification (TS) 21405 – Methodology and Framework for the Development and representation of IDMP Ontology, co-led by Sheila Elz, Bayer Pharma, and Vada Perkins, Boehringer-Ingelheim. The TS has a timeline of two years, with the target date for final publication July 2025.


  • Intro & Highlights from 2023
  • IDMP-O Release 1.0
  • Pharma Implementations
  • IDMP-O Plans 2024
  • Discussion

Please click here to view a recording of this event and other past webinars.